Online Database of Chemicals from Around the World

SDS 文件列表(按CAS登录号排序)

[ 2814500-04-2 ] - [ 2971088-37-4 ]

用户可以点击下表中相应的产品行,浏览或下载 CAS 号在 2814500-04-2 和 2971088-37-4 之间的产品的 SDS 文档样本。点击页面下方的各个CAS 号码分组,可以选择更多的产品。用户也可以使用页面上方的搜索框迅速得到所要查询的产品的 SDS 文档样本。

CAS 登录号 产品名称 分子式
2814500-04-2 (4-(3,6-Diphenyl-9H-carbazol-9-yl)butyl)phosphonic acid;Ph-4PACz Csub28/subHsub26/subNOsub3/subP
2816821-08-4 N-(diphenylmethylene)-6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-((triisopropylsilyl)ethynyl)naphthalen-2-amine;N-[6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-[2-tri(propan-2-yl)silylethynyl]naphthalen-2-yl]-1,1-diphenylmethanimine Csub40/subHsub47/subBFNOsub2/subSi
2820536-99-8 [(8S)-6-methylene-2,3,5,7-tetrahydro-1H-pyrrolizin-8-yl]methanol Csub9/subHsub15/subNO
2836267-80-0 5,7-Dichloro-8-fluoro-1H-pyrido[4,3-D]pyrimidine-2,4-dione Csub7/subHsub2/subClsub2/subFNsub3/subOsub2/sub
2865162-09-8 Benzyl (S)-4-(5-(5-bromo-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)-1H-indol-2-YL)-6-(1-methoxyethyl)pyridin-3-YL)piperazine-1-carboxylate;benzyl 4-[5-[5-bromo-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)indol-2-yl]-6-[(1S)-1-methoxyethyl]pyridin-3-yl]piperazine-1-carboxylate Csub35/subHsub43/subBrNsub4/subOsub4/sub
2869954-34-5 Werner syndrome RecQ helicase-IN-1;HRO761; N-[2-chloro-4-(trifluoromethyl)phenyl]-2-[2-(3,6-dihydro-2H-pyran-4-yl)-5-ethyl-6-[4-(5-hydroxy-6-methylpyrimidine-4-carbonyl)piperazin-1-yl]-7-oxo-[1,2,4]triazolo[1,5-a]pyrimidin-4-yl]acetamide Csub31/subHsub31/subClFsub3/subNsub9/subOsub5/sub
2875067-31-3 (R)-4,4,4-Trifluoro-3-hydroxy-3-methylbutan-2-one;(3R)-4,4,4-trifluoro-3-hydroxy-3-methylbutan-2-one Csub5/subHsub7/subFsub3/subOsub2/sub
2915356-76-0 Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH;Tirzepatide sidechain Csub66/subHsub10/subsub5/subNsub5/subOsub16/sub
2922526-56-3 (4-(3,6-Dimethoxy-9h-carbazol-9-yl)butyl)phosphonic acid;MeO-4PACz Csub18/subHsub22/subNOsub5/subP
2922732-54-3 RMC-9805;KRAS G12D inhibitor 18; (2S)-2-cyclopentyl-2-[(5S)-2-[(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl]-2,7-diazaspiro[4.4]nonan-7-yl]-N-[(6S,8S,14S)-21-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]pyridin-3-yl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]acetamide Csub63/subHsub88/subFsub3/subNsub11/subOsub7/sub
2937344-16-4 BI-2493;KRAS INHIBITOR; (7S)-2'-amino-3-[2-[(2S)-2-methylpiperazin-1-yl]pyrimidin-4-yl]spiro[5,6-dihydro-4H-1,2-benzoxazole-7,4'-6,7-dihydro-5H-1-benzothiophene]-3'-carbonitrile; (S)-2-amino-3'-(2-((S)-2-methylpiperazin-1-yl)pyrimidin-4-yl)-5',6,6',7-tetrahydro-4'H,5H-spiro[benzo[b]thiophene-4,7'-benzo[d]isoxazole]-3-carbonitrile Csub24/subHsub27/subNsub7/subOS
2971088-37-4 (4-(2,7-Dibromo-9,9-dimethylacridin-10(9H)-yl)butyl)phosphonic acid Csub19/subHsub22/subBrsub2/subNOsub3/subP

浏览其它 SDS 列表
1523571-10-9 to 1557267-42-1   1557849-73-6 to 1599466-81-5   1599466-83-7 to 1613724-42-7   1613751-69-1 to 1628047-87-9   1628208-23-0 to 1642288-47-8   1642298-59-6 to 1674334-59-8   1675201-14-5 to 1708092-13-0   1708118-13-1 to 1793053-37-8   1793105-28-8 to 1802175-06-9   1802242-47-2 to 1812890-23-5   1814936-54-3 to 1854067-25-6   1854067-37-0 to 1893125-36-4   1895296-01-1 to 1956385-35-5   1956426-56-4 to 2055043-54-2   2055043-62-2 to 2093387-36-9   2093414-16-3 to 2144748-14-9   2148296-04-0 to 2201839-83-8   2204863-06-7 to 2239295-71-5   2241140-83-8 to 2308507-34-6   2311888-27-2 to 2409562-95-2   2410075-48-6 to 2565657-65-8   2565657-83-0 to 2803372-49-6